Generic Name and Formulations:
Olopatadine (as HCl) 0.6% (665mcg/spray); aqueous nasal spray; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for PATANASE:
Seasonal allergic rhinitis.
2 sprays in each nostril twice daily.
<6yrs: not recommended. 6–11yrs: 1 spray in each nostril twice daily.
Other nasal diseases: not recommended. Avoid eyes. Monitor for nasal mucosal changes. Discontinue if nasal ulceration develops. Pregnancy (Cat.C). Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants.
Bitter taste, headache, epistaxis, throat pain, post-nasal drip, cough, UTIs, nasal ulceration, nasal septal perforation, somnolence; children also: upper respiratory tract infection, pyrexia, rash.
Nasal spray pump—30.5g (240 sprays)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age